World's Best Scientists 2026 revealed!
Nicola Silvestris

Nicola Silvestris

D-Index & Metrics

Biology and Biochemistry

D-Index
65
Citations
12206
World Ranking
9357
National Ranking
257

Nicola Silvestris publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Nicola Silvestris sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 430 publications — 92nd percentile

92% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Nicola Silvestris D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Nicola Silvestris sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 65 D-Index — 55th percentile

55% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Nicola Silvestris is affiliated with the University of Messina in Italy and has contributed extensively to the fields of medicine and molecular biology, with a particular focus on oncology.

Their research spans a variety of subfields, including oncology, molecular biology, cancer research, immunology, and pulmonary and respiratory medicine. Key topics of their work encompass cancer immunotherapy and biomarkers, pancreatic and hepatic oncology research, COVID-19 clinical research studies, SARS-CoV-2 and COVID-19 research, cancer genomics and diagnostics, colorectal cancer treatments and studies, and immunotherapy and immune responses.

Recent significant papers authored or co-authored by Nicola Silvestris include:

  • Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial, 2020, The Lancet Oncology
  • Liquid biopsy and tumor heterogeneity in metastatic solid tumors: the potentiality of blood samples, 2020, Journal of Experimental & Clinical Cancer Research
  • Incidence of patients with bone metastases at diagnosis of solid tumors in adults: a large population-based study, 2020, Annals of Translational Medicine
  • Current Approaches for Combination Therapy of Cancer: The Role of Immunogenic Cell Death, 2020, Cancers
  • Combination of Ipilimumab and Nivolumab in Cancers: From Clinical Practice to Ongoing Clinical Trials, 2020, International Journal of Molecular Sciences

Nicola Silvestris has collaborated frequently with several co-authors, including:

  • Oronzo Brunetti
  • Afshin Derakhshani
  • Antonella Argentiero
  • Behzad Baradaran
  • Vito Racanelli

Publications by Nicola Silvestris appear regularly in various scientific venues, notably:

  • Frontiers in Oncology
  • Cancers
  • Preprints.org
  • ESMO Open
  • International Journal of Molecular Sciences

Their academic output reflects contributions to cancer immunotherapy and biomarker discovery, as well as oncological studies on pancreatic, hepatic, and colorectal cancers, alongside research related to the COVID-19 pandemic. The integration of clinical trials and translational research is seen in their publications, which cover treatment protocols and molecular diagnostic approaches.

Best Publications

  • Liquid biopsy and tumor heterogeneity in metastatic solid tumors: the potentiality of blood samples

    Marco Russano;Andrea Napolitano;Giulia Ribelli;Michele Iuliani

  • Plasma-activated medium triggers cell death and the presentation of immune activating danger signals in melanoma and pancreatic cancer cells.

    Amalia Azzariti;Rosa Maria Iacobazzi;Roberta Di Fonte;Letizia Porcelli

  • Natural history of bone metastasis in colorectal cancer: final results of a large Italian bone metastases study

    D. Santini;M. Tampellini;B. Vincenzi;T. Ibrahim

  • Incidence of patients with bone metastases at diagnosis of solid tumors in adults: a large population-based study.

    Jin-Feng Huang;Jianfei Shen;Xiao Li;Ramesh Rengan

  • Hospital admission of cancer patients: avoidable practice or necessary care?

    Gianmauro Numico;Antonella Cristofano;Alessandro Mozzicafreddo;Olga Elisabetta Cursio

  • Prognostic vs predictive molecular biomarkers in colorectal cancer: is KRAS and BRAF wild type status required for anti-EGFR therapy?

    Sergio Rizzo;Giuseppe Bronte;Daniele Fanale;Lidia Corsini

  • Current approaches for combination therapy of cancer: The role of immunogenic cell death

    Zahra Asadzadeh;Elham Safarzadeh;Sahar Safaei;Ali Baradaran

  • Dasatinib: an anti-tumour agent via Src inhibition.

    Antonio Gnoni;Ilaria Marech;Nicola Silvestris;Angelo Vacca

  • The role of inflammatory cytokines and tumor associated macrophages (TAMs) in microenvironment of pancreatic cancer.

    Saeed Farajzadeh Valilou;Mahsa Keshavarz-Fathi;Mahsa Keshavarz-Fathi;Nicola Silvestris;Antonella Argentiero

  • Expression and prognostic value of VEGFR-2, PDGFR-β, and c-Met in advanced hepatocellular carcinoma

    Jie Sheng Chu;Fei Jiao Ge;Bo Zhang;Yan Wang

  • Adjuvant colon cancer chemotherapy: where we are and where we'll go.

    L. Lombardi;F. Morelli;S. Cinieri;D. Santini

  • Human epidermal growth factor receptor 2 (HER2) in gastric cancer: a new therapeutic target.

    F. De Vita;F. Giuliani;N. Silvestris;G. Catalano

  • Immunotherapy for colorectal cancer: where are we heading?

    Debora Basile;Silvio Ken Garattini;Marta Bonotto;Elena Ongaro

  • High density of tryptase-positive mast cells in human colorectal cancer: a poor prognostic factor related to protease-activated receptor 2 expression.

    Andrea Malfettone;Nicola Silvestris;Concetta Saponaro;Girolamo Ranieri

  • Immune inflammation indicators and implication for immune modulation strategies in advanced hepatocellular carcinoma patients receiving sorafenib

    Andrea Casadei Gardini;Emanuela Scarpi;Luca Faloppi;Mario Scartozzi

  • Angiogenesis in pancreatic ductal adenocarcinoma: A controversial issue

    Vito Longo;Oronzo Brunetti;Antonio Gnoni;Stefano Cascinu

  • Gene Expression Comparison between the Lymph Node-Positive and -Negative Reveals a Peculiar Immune Microenvironment Signature and a Theranostic Role for WNT Targeting in Pancreatic Ductal Adenocarcinoma: A Pilot Study.

    Antonella Argentiero;Simona De Summa;Roberta Di Fonte;Rosa Maria Iacobazzi

  • New findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: do all roads lead to RAS?

    Giuseppe Bronte;Nicola Silvestris;Marta Castiglia;Antonio Galvano

  • Molecularly targeted endocrine therapies for breast cancer.

    L. Orlando;P. Schiavone;P. Fedele;N. Calvani

  • Metformin and insulin impact on clinical outcome in patients with advanced hepatocellular carcinoma receiving sorafenib: Validation study and biological rationale.

    Andrea Casadei Gardini;Luca Faloppi;Serena De Matteis;Francesco Giuseppe Foschi

Frequent Co-Authors

Daniele Santini
Daniele Santini Università Campus Bio-Medico
Behzad Baradaran
Behzad Baradaran Tabriz University of Medical Sciences
Stefano Cascinu
Stefano Cascinu Vita-Salute San Raffaele University
Antonio Russo
Antonio Russo University of Palermo
Angelo Paradiso
Angelo Paradiso National Cancer Research Institute, UK
Giuseppe Tonini
Giuseppe Tonini Università Campus Bio-Medico
Bruno Vincenzi
Bruno Vincenzi Università Campus Bio-Medico
Sara Lonardi
Sara Lonardi Istituto Oncologico Veneto
Aldo Scarpa
Aldo Scarpa University of Verona
Angelo Vacca
Angelo Vacca University of Bari Aldo Moro

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Biology and Biochemistry in the USA opens the door to a variety of online degree options and career pathways in healthcare, nutrition, and management. Many students pursue flexible online programs to balance their studies with work or other commitments.

Interested in food science or wellness? Consider a cheapest online nutrition degree to build a foundation in health and nutrition without breaking the bank. For those already in nursing, several online rn to bsn programs offer streamlined paths to advance your qualifications and job prospects.

If you're aiming for leadership roles, a degree in healthcare management can prepare you for management positions in hospitals, clinics, or biotech firms. There's also rising demand for mental health professionals—pursuing the fastest pmhnp program can equip you to become a psychiatric mental health nurse practitioner.

These related online degrees offer accessible, diverse pathways to fulfilling careers beyond traditional biology and biochemistry roles.

Best Scientists Citing Nicola Silvestris

Trending Scientists

Recently Published Articles